Clinical research law in Jordan: an ethical analysis |
| |
Authors: | Ramahi Ibrahim Silverman Henry |
| |
Institution: | Forensic Pathology &Clinical Forensic Medicine, National Institute of Forensic Medicine, MOH, Amman, Jordan; University of Maryland School of Medicine, USA |
| |
Abstract: | An ethical analysis of Jordan's Clinical Research Law, which became effective in 2001, was performed. Accordingly, this paper discusses the major components, key strengths and weaknesses of this law. As an initial effort, the Law addresses important aspects of research ethics and, hence, should serve as an example for other Arab Countries in the Middle East. Unique aspects of the Law include the requirement that those conducting any study have insurance that can compensate for research injuries and a system of fines and punishments for noncompliance with the Law. There are, however, some key items missing in the Jordanian Law. For example, the Law does not mention the requirement of a favourable assessment of risks and benefits, the fair selection of subjects, or articles regarding the protection of the rights and welfare of children and other vulnerable subjects participating in research. The paper concludes with the suggestion that new amendments should be considered for future revisions of the Clinical Research Law in Jordan. |
| |
Keywords: | research ethics clinical trials developing world informed consent pharmaceutical |
本文献已被 PubMed 等数据库收录! |
|